Refractory ascites can significantly reduce quality of life in patients with advanced stage ovarian cancer. Paracentesis is a commonly used procedure for the management of refractory ascites. However, there are potential risks associated with paracentesis such as pain, infection, and injury to intra-abdominal organs. In an effort to decrease the number of serial paracentesis, placement of intraperitoneal catheters has been described for the management of intractable ascites. Here we describe a case of metastasis involving a palliative peritoneal catheter in a patient with recurrent ovarian cancer.
BrooksRAHerzogTJ.Long-term semi-permanent catheter use for the palliation of malignant ascites. Gynecol Oncol. 2006;101(2):360–362.
2.
IyengarTDHerzogTJ.Management of symptomatic ascites in recurrent ovarian cancer patients using an intra-abdominal semi-permanent catheter. Am J Hosp Palliat Care. 2002;19(1):35–38.
3.
WarnockNGRileyM.Implantation metastasis alongside an intraperitoneal chemotherapy catheter in ovarian carcinoma. Abdom Imaging. 1995;20(3):262–263.
4.
CormioGCapotortoMVagnoGDCazzollaACarrieroCSelvaggiL.Skin metastases in ovarian carcinoma: a report of nine cases and a review of the literature. Gynecol Oncol. 2003;90(3):682–685.
5.
ChapmanWCSharpKWWeaverFSawyersJL.Tumor seeding from percutaneous biliary catheters. Ann Surg. 1989;209(6):708–713.discussion 713-705
